Avalon GloboCare Corp. ALBT

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    -$3.17 (-29.08%)Past DayToday's Volume:
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Business overview of Avalon GloboCare Corp. (ALBT)
    Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

    Key Insights

    Critical company metrics and information

    • Latest Closing Price

      $7.23

    • Market Cap

      $7.91 Million

    • Price-Earnings Ratio

      0.03

    • Total Outstanding Shares

      1.09 Million Shares

    • Total Employees

      5

    • Dividend

      No dividend

    • IPO Date

      February 22, 2016

    • SIC Description

      Biological Products, (no Disgnostic Substances)

    • Primary Exchange

      NASDAQ

    • Type

      Common Stock

    • Headquarters

      4400 route 9, Freehold, NJ, 07728

    • Homepage

      https://www.avalon-globocare.com

    Historical Stock Splits

    If you bought 150 shares of ALBT before January 5, 2023, you'd have 1 share today.
    Execution DateSplit Amount
    October 28, 20241-for-15 (Reverse Split)
    January 5, 20231-for-10 (Reverse Split)

    Cash Flow Statement

    October 1, 2023 to September 30, 2024
    MetricValue
    Net Cash Flow From Financing Activities, Continuing$5.46 Million
    Net Cash Flow From Investing Activities, Continuing$-99,988
    Net Cash Flow From Financing Activities$5.46 Million
    Net Cash Flow, Continuing$673,659
    Exchange Gains/Losses$8,767
    Net Cash Flow From Operating Activities$-4.69 Million

    Income Statement

    October 1, 2023 to September 30, 2024
    MetricValue
    Costs And Expenses$-1.91 Million
    Diluted Average Shares$33.01 Million
    Nonoperating Income/Loss$-1.33 Million
    Net Income/Loss Attributable To Parent$-14.73 Million
    Net Income/Loss$-14.73 Million
    Revenues$1.31 Million

    Comprehensive Income

    October 1, 2023 to September 30, 2024
    MetricValue
    Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
    Other Comprehensive Income/Loss$479
    Comprehensive Income/Loss$-14.73 Million
    Comprehensive Income/Loss Attributable To Parent$-14.73 Million

    Balance Sheet

    October 1, 2023 to September 30, 2024
    MetricValue
    Current Liabilities$12.33 Million
    Equity Attributable To Parent$5.40 Million
    Intangible Assets$8.89 Million
    Noncurrent Liabilities$1.82 Million
    Fixed Assets$31,163
    Noncurrent Assets$18.15 Million

    Historical Dividends

    Announcement DatePayment DateRecord DateAmountFrequency
    No historical dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about ALBT from trusted financial sources
      Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
      All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

      ⓒ 2025 Financhle. All Rights Reserved.